BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36847128)

  • 1. RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transition.
    Shao IH; Peng PH; Wu HH; Chen JL; Lai JC; Chang JS; Wu HT; Wu KJ; Pang ST; Hsu KW
    Cancer Med; 2023 Apr; 12(8):9788-9801. PubMed ID: 36847128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of epithelial-mesenchymal transition (EMT) by hypoxia-induced lncRNA
    Peng PH; Lai JC; Chang JS; Hsu KW; Wu KJ
    Am J Cancer Res; 2021; 11(6):2618-2636. PubMed ID: 34249418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis.
    Peng PH; Chen JL; Wu HH; Yang WH; Lin LJ; Lai JC; Chang JS; Syu JL; Wu HT; Hsu FT; Cheng WC; Hsu KW
    Cancer Cell Int; 2023 Nov; 23(1):266. PubMed ID: 37941005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
    Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
    Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-induced lncRNA RP11-390F4.3 promotes epithelial-mesenchymal transition (EMT) and metastasis through upregulating EMT regulators.
    Peng PH; Chieh-Yu Lai J; Hsu KW; Wu KJ
    Cancer Lett; 2020 Jul; 483():35-45. PubMed ID: 32353468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma.
    Wang Y; Feng YC; Gan Y; Teng L; Wang L; La T; Wang P; Gu Y; Yan L; Li N; Zhang L; Wang L; Thorne RF; Zhang XD; Cao H; Shao FM
    J Exp Clin Cancer Res; 2022 Aug; 41(1):260. PubMed ID: 36028903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.
    Chang L; Wang J; Zhou F; Wang D; Chen R; Zhang Y; Zhang J
    J Neurooncol; 2021 Jan; 151(2):157-171. PubMed ID: 33128099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of artesunate on long noncoding RNA-RP11 to inhibit epithelial-mesenchymal transition of hepatocellular carcinoma.
    Jing W; Dong H; Min M; Runpeng Z; Xuewei X; Ru C; Yingru X; Shengfa N; Baoxian T; Jinbo Y; Weidong H; Rongbo Z
    J Cell Biochem; 2019 Apr; 120(4):6026-6034. PubMed ID: 30335897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
    Xu J; Wang Y; Jiang J; Yin C; Shi B
    J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA LINC00667 gets involved in clear cell renal cell carcinoma development and chemoresistance by regulating the miR-143-3p/ZEB1 axis.
    Zhao J; Chen P; Tan C; Cheng X; Zhang W; Shen C; Zhang D
    Aging (Albany NY); 2023 Oct; 15(19):10057-10071. PubMed ID: 37827696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.
    Dasgupta P; Kulkarni P; Majid S; Shahryari V; Hashimoto Y; Bhat NS; Shiina M; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
    Mol Cancer Ther; 2018 May; 17(5):1061-1069. PubMed ID: 29440295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis.
    Kulkarni P; Dasgupta P; Hashimoto Y; Shiina M; Shahryari V; Tabatabai ZL; Yamamura S; Tanaka Y; Saini S; Dahiya R; Majid S
    Cancer Res; 2021 Mar; 81(6):1500-1512. PubMed ID: 33500248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma.
    Wang K; Jin W; Song Y; Fei X
    Mol Cancer; 2017 Oct; 16(1):166. PubMed ID: 29070041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.
    Xiang W; Lv L; Zhou G; Wu W; Yuan J; Zhang C; Jiang G
    Cancer Med; 2020 Jun; 9(12):4251-4264. PubMed ID: 32281285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma.
    Ning L; Li Z; Wei D; Chen H; Yang C
    Cancer Biomark; 2017; 19(1):75-83. PubMed ID: 28269753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formin-related protein 1 facilitates proliferation and aggressive phenotype of clear cell renal cell carcinoma through MAPK/MMP2 pathway.
    Ma G; Zhang B; Fu S; Lu J; Zhang L; Shang P; Yue Z
    Mol Cell Probes; 2023 Oct; 71():101921. PubMed ID: 37454877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.